Noble Wealth Management PBC’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
FWCM
DLA
FFA
GI
CT
LJHT
BFA
GI
PNC
VCM
Noble Wealth Management PBC's NVS Position: Q3 2026 in Review
Noble Wealth Management PBC sold out of Novartis (NVS) in Q3 2026, closing a stake of 8 shares — an estimated $1.25K sold.
Noble Wealth Management PBC first reported a position in NVS in Q2 2026 and held it in 1 quarter. The position peaked at $1.25K in Q2 2026. 83 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Noble Wealth Management PBC reported no remaining Novartis position as of Q3 2026 after selling out during the quarter.
- Noble Wealth Management PBC sold 8 Novartis shares in Q3 2026, an estimated $1.25K.
- Noble Wealth Management PBC first reported a position in Novartis in Q2 2026 and held it in 1 quarter.
- Noble Wealth Management PBC's Novartis position peaked at $1.25K in Q2 2026.
- 83 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.